Yao-Wei W Wang Selected Research

Heparitin Sulfate (Heparan Sulfate)

1/2023

A 3-O-sulfated heparan sulfate dodecasaccharide (12-mer) suppresses thromboinflammation and attenuates early organ injury following trauma and hemorrhagic shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yao-Wei W Wang Research Topics

Disease

7	Wounds and Injuries (Trauma) 01/2023 - 09/2012
5	Hemorrhage 01/2023 - 07/2011
2	Shock 01/2023 - 07/2014
1	Inflammation (Inflammations) 10/2023
1	Hemorrhagic Shock 01/2023
1	Thromboinflammation 01/2023
1	Venous Thromboembolism 01/2022
1	Thrombophilia 07/2014
1	Atherosclerosis 06/2008
1	Coronary Disease (Coronary Heart Disease) 06/2008

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
2	Thrombin FDA Link 09/2014 - 07/2014
2	Hemostatics (Antihemorrhagics)IBA 07/2014 - 07/2011
1	Ion Channels (Ion Channel)IBA 10/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2023
1	antithrombin III-protease complexIBA 01/2023
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2022
1	AntithrombinsIBA 01/2022
1	Factor Xa (Coagulation Factor Xa)IBA 01/2022
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 07/2013
1	Thromboplastin (Tissue Factor)IBA 09/2012
1	ThrombomodulinIBA 06/2008
1	Plasminogen Activators (Plasminogen Activator)IBA 06/2008
1	Blood Coagulation Factors (Coagulation Factor)IBA 06/2008
1	Fibrinogen (Factor I)FDA Link 06/2008
1	Factor VIII (Coagulation Factor VIII)IBA 06/2008

Therapy/Procedure

3	Resuscitation 01/2023 - 07/2013
1	Laparotomy 01/2023
1	Catheters 07/2014
1	Punctures 07/2014
1	Hemodilution 10/2013